STOCK TITAN
  1. Home
  2. News
  3. ECOR

electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
earnings

ROCKAWAY, NJ, July 22, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2021 after the close of the market on Thursday, August 5, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.


Thursday, August 5, 2021, 4:30pm Eastern Time
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 748491
Webcast: electroCore 2Q21 Business Update Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.


Stock ECOR logo
electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

#4892 Ranked by Market Cap
#411 Ranked by Stock Gains
N/A Ranked by Dividends

ECOR Latest News

May 3, 2024
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
May 1, 2024
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
Apr 30, 2024
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
Apr 8, 2024
electroCore Announces the Launch of Truvaga Plus® for General Wellness
Apr 2, 2024
electroCore Expands Intellectual Property Portfolio

ECOR Stock Data

37.97M
4.17M
18.51%
16.59%
0.17%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
ROCKAWAY

About ECOR

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.